title: Cancer-related anaemia requires higher doses of epoetin alfa than chronic renal failure replacement therapy.
authors.forename: L M
authors.initials: LM
authors.lastname: Itri
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D004305:Dose-Response Relationship, Drug; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage* / Q000627:therapeutic use; D006397:Hematinics / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D009369:Neoplasms / Q000097:blood*; D011994:Recombinant Proteins
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa